Cowen Financial Products LLC 13D and 13G filings for Exagen Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-02 3:16 pm Sale | 2023-12-29 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 898,630 5.270% | -67,392 (-6.98%) | Filing |
| 2023-01-23 5:13 pm Sale | 2022-12-30 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 966,022 5.920% | -418,609 (-30.23%) | Filing |
| 2022-01-20 10:46 am Unchanged | 2021-12-31 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 1,384,631 8.570% | 0 (Unchanged) | Filing |
| 2022-01-19 4:21 pm Purchase | 2021-12-31 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 1,384,631 8.570% | 511,000 (+58.49%) | Filing |
| 2021-12-17 3:57 pm Purchase | 2021-09-10 | 13G | Exagen Inc. XGN | Cowen Financial Products LLC | 873,631 5.410% | 873,631 (New Position) | Filing |